Rein Therapeutics RNTX
NASDAQ RNTX
$0.62 +0.03 (+4.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Minority Interest (2016 - 2017)

Updated

Rein Therapeutics (RNTX) reported Minority Interest of $130.41 million for Q2 2017.

Analysis

Rein Therapeutics (RNTX) Minority Interest (2016 - 2017) Analysis & Trends

At the end of FY2016, Rein Therapeutics posted Minority Interest of $129.75 million, up 32.8% from FY2015.

  • By year, Minority Interest came in at $97.68 million in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Rein Therapeutics 42.04 Mn -1.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 130.41 Mn
Dec 31, 2016 129.75 Mn
API Access

Rein Therapeutics Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=RNTX&period=max&api_key=YOUR_API_KEY